Cedric Peters
@CedricPetersRT
Followers
146
Following
1K
Media
1
Statuses
307
RT @drdavidpalma: Here's a patient recently randomized on our ARREST2 phase 2/3 RCT. Sixteen pulmonary mets, 35 Gy in 5 fractions. Cons….
0
42
0
RT @toddscarbrough: Radiation Forgiveness. & Re-irradiation. & Monkeys 🙈🙊🙉.============. I derived a simple equation to use "in clinico". T….
0
9
0
RT @VickersBiostats: The Gleason score - the fundamental determinant of how we chose on treatments in localized prostate cancers - basicall….
0
13
0
RT @joshuapalmermd: Excited to share our experience (largest so far) using Boswellia for radiation necrosis with brain mets. ORR 60%, media….
pubmed.ncbi.nlm.nih.gov
Our study suggests that BS is a safe and feasible treatment option for grade 1 to 3 RN after SRS. Further prospective studies comparing BS with a placebo are warranted.
0
24
0
RT @Erman_Akkus: ☢️Pancreatic SBRT and toxicity.@JNCCN . ➡️2 decades, 507 patients.🚨Early (90days) toxicity: Infection.❗️Severe GI toxicity….
0
11
0
RT @tomaspueyo: Lots of this regulation is caused by the LNT model (linear non-threshold model), which assumes that any bit of radiation is….
0
4
0
RT @gerryhanna: When I started oncology training there was a very minimal place for radiotherapy in the treatment of #ovariancancer. System….
0
12
0
RT @DrewMoghanaki: If you’re curious what @_ShankarSiva is up to next, say hello to the recently funded phase III randomized PRIME-LUNG stu….
0
10
0
RT @Uromigos: The highlight of #ASCO25 was the AMPLITUDE trial presented by @AttardLab on PARPi in HRR altered mHSPC. Listen to our podcast….
0
32
0
RT @jryckman3: 🧵1/. Big news in unresectable stage III NSCLC. The InTRist study is the first randomized trial comparing NAC vs. neoadjuvan….
0
40
0
RT @DrewMoghanaki: Am I the only one questioning the “unbridled enthusiasm” for cCRT that is based the phase III RTOG 9410 study conducted….
0
10
0
RT @Bart_DeWever: Last week, I was a guest speaker at @idualliance, a platform of center-right political forces founded in the 1980s by fig….
0
108
0
RT @SeanPitroda: Excited to share our recent @Nature paper!. Tremendous collaborative effort from @UCCancerCenter….
0
43
0
RT @RnaudBertrand: I rarely praise Trump but this is a genuinely incredible speech I've been arguing for close to….
0
5K
0
RT @NiuSanford: Comparison of toxicity w 3D v IMRT in RAPIDO: IMRT worse. Table summarizes studies of 3D v IMRT in rectal ca – w RAPIDO, d….
0
34
0
RT @piet_ost: 📊 Breaking! FLAME trial 10-yr results show focal boost to MRI-visible tumors significantly improves outcomes in intermediate/….
0
43
0
RT @StasLazarev: @SimonLo21054188 @joshuapalmermd @jryckman3 @ASCO @NatRevClinOncol But does it really half the growth? Stable disease no d….
0
2
0
RT @TimothyJBrownMD: Excited to share our recent article "Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to….
journals.lww.com
cted RT to atezolizumab and bevacizumab (A/B) in patients with advanced HCC. Methods: This was a single-center retrospective cohort study of patients with HCC naive to systemic therapy who received...
0
16
0
RT @gerryhanna: Might PET based inhomogenous dose escalation be an approach to permit dose escalation in stage 3 #lungcancer /#NSCLC?. ➡️Wi….
0
6
0